Sagimet Biosciences Inc. SGMT
Set alert
9.92 USD -0.51 -4.89%
At close · Oct 30
9.92 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
9.82 Day range 10.54
4.55 52-week range 11.17
- YTD
- +67.57%
- 1 year
- +21.87%
- Open
- 10.41
- Prev close
- 10.43
- Mkt cap
- 703.41M
- Vol
- 989.15K
- Avg vol
- 1.35M
- EPS
- -1.27
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.82
- High
- 10.54
- Forward P/E
- -1.40
- Beta
- 0.00
- Short ratio
- 1.37
- Inst. own
- 66.94%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 5.28
- 200-d avg
- 4.27
- 1y target
- 29.14
Financial health
Altman Z-Score
25.15 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -3.7×
FY 2019 5y median -3.7× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.7×
FY 2019 5y median 0.9× FY 2025
P/FCF -4.2×
FY 2019 5y median -4.2× FY 2025
EV/EBITDA -3.1×
FY 2019 5y median -3.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -23.8%
FY 2019 5y median -23.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -45.8%
FY 2019 5y median -29.2% FY 2025
ROIC -51.0%
FY 2019 5y median -41.8% FY 2025
ROA -43.8%
FY 2019 5y median -41.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -4.5%
FY 2019 FY 2025
EPS (diluted) -9.0%
FY 2019 FY 2025
Free Cash Flow -7.6%
FY 2019 FY 2025
Financial Health
Current Ratio 22.8×
FY 2019 5y median 22.8× FY 2025
Quick Ratio 22.8×
FY 2019 5y median 22.8× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2019 5y median 1.7× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31